- Home
- NWPX vs ALT Comparison
NWPX vs ALT Comparison
Compare NWPX & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWPX
- ALT
- Stock Information
- Founded
- NWPX 1966
- ALT 1997
- Country
- NWPX United States
- ALT United States
- Employees
- NWPX N/A
- ALT N/A
- Industry
- NWPX Steel/Iron Ore
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- NWPX Industrials
- ALT Health Care
- Exchange
- NWPX Nasdaq
- ALT Nasdaq
- Market Cap
- NWPX N/A
- ALT 472.3M
- IPO Year
- NWPX 1995
- ALT N/A
- Fundamental
- Price
- NWPX $42.78
- ALT $4.76
- Analyst Decision
- NWPX Hold
- ALT Strong Buy
- Analyst Count
- NWPX 1
- ALT 6
- Target Price
- NWPX $55.00
- ALT $20.20
- AVG Volume (30 Days)
- NWPX 55.8K
- ALT 11.3M
- Earning Date
- NWPX 07-30-2025
- ALT 08-07-2025
- Dividend Yield
- NWPX N/A
- ALT N/A
- EPS Growth
- NWPX 37.25
- ALT N/A
- EPS
- NWPX 3.27
- ALT N/A
- Revenue
- NWPX $495,448,000.00
- ALT $20,000.00
- Revenue This Year
- NWPX $1.41
- ALT N/A
- Revenue Next Year
- NWPX $6.07
- ALT $1,557,547.90
- P/E Ratio
- NWPX $12.96
- ALT N/A
- Revenue Growth
- NWPX 8.06
- ALT N/A
- 52 Week Low
- NWPX $32.29
- ALT $2.90
- 52 Week High
- NWPX $57.76
- ALT $11.16
- Technical
- Relative Strength Index (RSI)
- NWPX 69.04
- ALT 42.91
- Support Level
- NWPX $38.38
- ALT $3.30
- Resistance Level
- NWPX $42.99
- ALT $7.73
- Average True Range (ATR)
- NWPX 1.14
- ALT 0.59
- MACD
- NWPX 0.40
- ALT -0.27
- Stochastic Oscillator
- NWPX 95.03
- ALT 38.51
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.